Results 71 to 80 of about 7,086 (183)

Disseminated Mixed Lytic‐Sclerotic Skeletal Metastases as Initial Presentation of Gallbladder Carcinoma: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Gallbladder carcinoma is an aggressive malignancy often diagnosed at an advanced stage. Skeletal metastasis, especially mixed lytic‐sclerotic lesions, is rare and typically occurs late. This report highlights an unusual presentation where widespread bony metastases were the initial manifestation, leading to the diagnosis of gallbladder ...
Shivali Rao   +2 more
wiley   +1 more source

Xanthoma Disseminatum with Tumor-Like Lesion on Face

open access: yesCase Reports in Dermatological Medicine, 2014
Xanthoma disseminatum (XD) is a rare benign mucocutaneous xanthomatosis that is classified as a benign non-Langerhans cell histiocytosis. We report a 62-year-old man who presented with widespread yellow-brown papulonodular and tumoral lesions on face ...
Habib Ansarin   +3 more
doaj   +1 more source

Baby with neonatal systemic juvenile xanthogranuloma born within a cross-cousin marriage

open access: yesDermatologica Sinica, 2015
Juvenile xanthogranuloma is a non-Langerhans cell histiocytosis seen most commonly in childhood and adolescence. Extracutaneous involvement is rare. We report an interesting and extremely rare case of systemic (skin, lung, spleen, and colon) “juvenile ...
Hikmet Tekin Nacaroglu   +6 more
doaj   +1 more source

A large multilobulated cutaneous nodule in infancy

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Hannah Wahida   +2 more
wiley   +1 more source

Behavior Change Interventions to Promote Healthy Lifestyles Among Adolescent and Young Adult Childhood Cancer Survivors: A Scoping Review

open access: yesCancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Adolescent and young adult childhood cancer survivors (AYA‐CCS) face elevated risks of chronic health conditions and premature mortality further exacerbated by poor lifestyle behaviors including physical inactivity, poor nutrition, and substance use.
C. Gélinas‐Gagné   +11 more
wiley   +1 more source

Multiple cutaneous reticulohistiocytoma

open access: yesIndian Journal of Dermatology, 2016
Multicentric reticulohistiocytosis is a rare non-Langerhans cell histiocytosis characterized in its full form by severe destructive arthritis, cutaneous nodules, and systemic manifestations.
Karishma D Hemmady   +2 more
doaj   +1 more source

Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. [PDF]

open access: yesBlood Adv, 2023
Aaroe A   +12 more
europepmc   +1 more source

MEK inhibition achieves robust and durable responses in Erdheim–Chester disease

open access: yesHemaSphere, Volume 10, Issue 10, October 2026.
Abstract Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm characterized by heterogeneous clinical manifestations and limited evidence to guide targeted therapy. While MEK inhibitors (MEKi) are increasingly used, data on their real‐world efficacy, durability, and safety remain incomplete.
Francesco Pegoraro   +34 more
wiley   +1 more source

Juvenile Xanthogranuloma: Case Report and Literature Review

open access: yesInternational Medical Case Reports Journal, 2020
Sadegh Vahabi-Amlashi, Masoumeh Hoseininezhad, Zahra Tafazzoli Cutaneous Leishmaniasis Research Center, Mashhad University of Medical Sciences, Mashhad, IranCorrespondence: Zahra TafazzoliDepartment of Dermatology, Imam Reza Hospital, Ibn e Sina Street ...
Vahabi-Amlashi S   +2 more
doaj  

Adult‐Onset Central Nervous System Erdheim–Chester Disease Successfully Treated With Cladribine and Cytarabine: Case Report and Literature Review

open access: yeseJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Erdheim–Chester disease (ECD) is a rare histiocytic disorder with heterogeneous clinical manifestations. Central nervous system (CNS) involvement is associated with poor prognosis. Although targeted therapies have improved outcomes in patients with mitogen‐activated protein kinase (MAPK) pathway alterations, optimal treatment strategies for ...
Naoki Watanabe   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy